Meeting Banner
Abstract #1440

A marker for hyperacute ischemic stroke at ultra-low magnetic field

Mathieu Sarracanie1,2,3, Fanny Herisson4, Najat Salameh1,2,3, Cenk Ayata4, and Matthew Rosen1,2,3

1MGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States, 2Harvard Medical School, Boston, MA, United States, 3Department of Physics, Harvard University, Cambridge, MA, United States, 4Department of Radiology, MGH/Neurovascular Research Lab, Boston, MA, United States

Ischemic stroke treatment with a thrombolytic agent given in the hyperacute phase can greatly impact the outcome for stroke patients, however stroke status monitoring with CT and MRI is generally only possible once patients are admitted to a hospital. Here, we demonstrate T1 contrast at ultra-low magnetic field strength in a rat model of stroke, with subtle changes noticeable as early as t=20min, and more clearly at t=3h and t=24h following stroke onset. We believe that the use of portable, ultra-low field MRI scanners as an early-detection methodology could have great impact on the treatment and monitoring of ischemic stroke.

This abstract and the presentation materials are available to members only; a login is required.

Join Here